Rare diseases
Investigational molecules
Locations
Back to Poland33 clinical trials in Grodzisk Mazowiecki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction
PolandStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Preserved Ejection Fraction
PolandStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
PolandLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
PolandStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
PolandStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
PolandStudy on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis
PolandStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
PolandThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials exploring treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies focus on innovative therapies for heart failure and post-myocardial infarction care.
Researchers are evaluating novel compounds like asundexian and obicetrapib for improving cardiovascular outcomes.
Comprehensive studies investigating treatments for various autoimmune disorders, including psoriatic arthritis and multiple sclerosis. Research focuses on targeted therapies and disease-modifying treatments.
Novel biologics and immunomodulators are being tested to improve patient outcomes.
Innovative research into treatments for chronic obstructive pulmonary disease, examining new therapeutic approaches for managing moderate to severe cases.
Studies evaluate medications like tezepelumab and benralizumab for improving respiratory outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
